Esophageal pH monitoring, the current gold standard for diagnosis of gastroesophageal reflux disease (GERD), is by use of either a catheter (wired) or a wireless pH probe. Done through the catheter, wired monitoring usually causes side effects, for example, nausea, extreme discomfort, and bleeding. The other wireless option is using a pH sensing capsule to measure pH levels in the esophagus and transmit readings by radio telecommunications to a receiver.
However, there are some disadvantages of incumbent wireless pH monitoring system. Problems that are frequently observed include failure to detect non-acid reflux, poor data reception, limited and non-intuitive control over symptoms and dining report (type, duration, severity, etc.). Despite its high cost, it is unable to correlate collected data with QoL in patients.
French IHU-Strasbourg and Show Chwan Memorial Hospital are jointly developing products overcoming the above disadvantages. We are confident that our products will soon be available in the global market with US FDA 510(k) approval and EU CE mark.
Fundraising Target：We will raise NT$30M Pre-A round for pursuing medical device approvals.